Goldline Pharmaceutical vs Recode Studios
A side-by-side look at GMP, price band, subscription and key dates.
| Details |
Goldline Pharmaceutical |
Recode Studios |
| Status |
Listed |
Listed |
| Issue Type |
SME |
SME |
| Price Band |
Rs 41.00 to Rs 43.00 |
Rs 150.00 to Rs 158.00 |
| Lot Size |
3,000 Shares |
800 Shares |
| Bidding Period |
12 May 2026 - 14 May 2026 |
05 May 2026 - 07 May 2026 |
| Listing Date |
19 May 2026 |
12 May 2026 |
| Current GMP |
₹16.75 |
₹55.1 |
| GMP % |
38.95% |
34.87% |
| Estimated Listing Gain |
+38.95% |
+34.87% |
| Listing Price |
₹59.75 |
₹213.10 |
| Retail |
139.51x |
67.67x |
| QIB |
1.31x |
3.54x |
| NII |
TBA |
TBA |
| Overall Subscription |
100.14x |
59.5x |
